Taken together, we identified Beclin1 as the miR-30a target in oral cancer, and present here first evidence of the essential role of exosomal-miR-30a in reducing acquired chemo-resistance in OSCC via regulation of autophagic and apoptotic markers (Figure 7). The gene discussed is BECN1; the disease is lip and oral cavity carcinoma.